Investment

down-icon
image
Invest in the world’s largest market with US Stocks

Features

down-icon
support-icon
Pro Tools for Pro Traders
Uncover the powerful trading features

Pro Features

icon
support-icon
Built for Investors
Experience investing with simplified features

Pockets

icon

Fees

Safety

Academy

down-icon

More

down-icon
support-icon
Support

About Us

arrow-icon

Pluang+

|

assetIcon

Smith & Nephew plc (SNN) Stock Price Today

Overview

Financial

Technicals

Analysis

Corporate Action

About

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.


Technical Indicators

|

|

|

Overall Summary

Bearish (8)

Neutral (3)

Bullish (16)


Performance

SNN ROI

arrow
+18.63%

% from 52W High

-2.1%
$30.98

52W Low: $21.55

26 Oct 2023

52W High: $31.64

10 Sep 2024


News

Pluang News
Pluang News

Globe Newswire

2mo

Global Alginate Dressing Market worth $1,129.4 million by - GlobeNewswire



People Also Bought

Pluang
Pluang
BMY
Bristol-Myers Squibb Co
-0.74%

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions



Let’s trade or invest in this asset by signing up or logging in!

register_card

Let’s trade or invest in this asset by signing up or logging in!

You can also download our app!

item